News Genpact finds $18tn in trapped AI value Genpact and analyst firm HFS Research recently published a new global study identifying four enterprise debts.
Market Access Capital discipline in biotech: Building enduring companies w... Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.
R&D Sponsored A New Framework to Engineer Breakthrough Value for Medicines A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
Digital From pilots to impact: What it really takes to scale GenAI i... It’s no longer about what GenAI can do. It’s about what it should do – and whether it can consistently deliver value at scale.
Digital Balancing innovation and implementation: Embracing agentic A... A three-stage framework guides organisations through their agentic AI journey, ensuring effective ecosystem development.
Digital A well-kept secret: Applying IEPs to accelerate digital heal... Akira Endo discovered mevastatin, a cholesterol-lowering breakthrough molecule in 1973.
News BlossomHill, VogenX and Latigo reveal IPO plans Three more biotechs have revealed their intentions to list on Nasdaq - BlossomHill, VogenX, and Latigo - as 2026 heads for a record IPO haul.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
